Phenformin Inhibits Hedgehog-Dependent Tumor Growth through a Complex I-Independent Redox/Corepressor Module
Citations Over TimeTop 10% of 2020 papers
Abstract
The antidiabetic drug phenformin displays potent anticancer activity in different tumors, but its mechanism of action remains elusive. Using Shh medulloblastoma as model, we show here that at clinically relevant concentrations, phenformin elicits a significant therapeutic effect through a redox-dependent but complex I-independent mechanism. Phenformin inhibits mitochondrial glycerophosphate dehydrogenase (mGPD), a component of the glycerophosphate shuttle, and causes elevations of intracellular NADH content. Inhibition of mGPD mimics phenformin action and promotes an association between corepressor CtBP2 and Gli1, thereby inhibiting Hh transcriptional output and tumor growth. Because ablation of CtBP2 abrogates the therapeutic effect of phenformin in mice, these data illustrate a biguanide-mediated redox/corepressor interplay, which may represent a relevant target for tumor therapy.
Related Papers
- → Hedgehog signalling: how to get from Smo to Ci and Gli(2006)120 cited
- → Hypoxia induces a hedgehog response mediated by HIF‐1α(2008)90 cited
- → Lipid metabolism fattens up hedgehog signaling(2017)62 cited
- → Smoothened overexpression activates hedgehog signaling in human hepatocarcinogenesis(2006)
- Inhibition of hedgehog signalling preventsexperimental fibrosis and induces regression ofestablished fibrosis(2012)